AbbVie, Akcea benefit from latest CHMP recommendations

AbbVie, Akcea benefit from latest CHMP recommendations

Source: 
Biopharma Dive
snippet: 

Eight more drugs have received approval recommendations from the committee that advises European regulators on what therapies to clear for market.